139 related articles for article (PubMed ID: 11955961)
1. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
Buchsbaum MS; Shihabuddin L; Hazlett EA; Schröder J; Haznedar MM; Powchik P; Spiegel-Cohen J; Wei T; Singer MB; Davis KL
Schizophr Res; 2002 May; 55(1-2):25-40. PubMed ID: 11955961
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia.
Bralet MC; Buchsbaum MS; DeCastro A; Shihabuddin L; Mitelman SA
Eur Arch Psychiatry Clin Neurosci; 2016 Sep; 266(6):481-94. PubMed ID: 26370275
[TBL] [Abstract][Full Text] [Related]
3. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes.
Mitelman SA; Shihabuddin L; Brickman AM; Hazlett EA; Buchsbaum MS
Am J Psychiatry; 2003 Dec; 160(12):2154-68. PubMed ID: 14638586
[TBL] [Abstract][Full Text] [Related]
4. Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia.
Diehl B; LaPresto E; Najm I; Raja S; Rona S; Babb T; Ying Z; Bingaman W; Lüders HO; Ruggieri P
Epilepsia; 2003 Apr; 44(4):559-64. PubMed ID: 12681005
[TBL] [Abstract][Full Text] [Related]
5. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cortical activity in schizophrenia.
Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
[TBL] [Abstract][Full Text] [Related]
7. Regional brain metabolism during auditory hallucinations in chronic schizophrenia.
Cleghorn JM; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman H; Szechtman B; Franco S; Dermer SW; Cook P
Br J Psychiatry; 1990 Oct; 157():562-70. PubMed ID: 2131139
[TBL] [Abstract][Full Text] [Related]
8. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
9. Ventricular enlargement in poor-outcome schizophrenia.
Davis KL; Buchsbaum MS; Shihabuddin L; Spiegel-Cohen J; Metzger M; Frecska E; Keefe RS; Powchik P
Biol Psychiatry; 1998 Jun; 43(11):783-93. PubMed ID: 9611667
[TBL] [Abstract][Full Text] [Related]
10. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
[TBL] [Abstract][Full Text] [Related]
11. Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry.
Molina V; Hernández JA; Sanz J; Paniagua JC; Hernández AI; Martín C; Matías J; Calama J; Bote B
Psychiatry Res; 2010 Oct; 184(1):16-22. PubMed ID: 20832256
[TBL] [Abstract][Full Text] [Related]
12. Caudate and putamen volumes in good and poor outcome patients with schizophrenia.
Buchsbaum MS; Shihabuddin L; Brickman AM; Miozzo R; Prikryl R; Shaw R; Davis K
Schizophr Res; 2003 Nov; 64(1):53-62. PubMed ID: 14511801
[TBL] [Abstract][Full Text] [Related]
13. Age-associated changes of cerebral glucose metabolic activity in both male and female deaf children: parametric analysis using objective volume of interest and voxel-based mapping.
Kang E; Lee DS; Kang H; Lee JS; Oh SH; Lee MC; Kim CS
Neuroimage; 2004 Aug; 22(4):1543-53. PubMed ID: 15275911
[TBL] [Abstract][Full Text] [Related]
14. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia.
Guich SM; Buchsbaum MS; Burgwald L; Wu J; Haier R; Asarnow R; Nuechterlein K; Potkin S
Schizophr Res; 1989; 2(6):439-48. PubMed ID: 2487185
[TBL] [Abstract][Full Text] [Related]
15. Functional brain imaging of a catatonic type of schizophrenia: PET and SPECT studies.
Satoh K; Narita M; Someya T; Fukuyama H; Yonekura Y
Jpn J Psychiatry Neurol; 1993 Dec; 47(4):881-5. PubMed ID: 8201798
[TBL] [Abstract][Full Text] [Related]
16. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism.
Siegel BV; Asarnow R; Tanguay P; Call JD; Abel L; Ho A; Lott I; Buchsbaum MS
J Neuropsychiatry Clin Neurosci; 1992; 4(4):406-14. PubMed ID: 1422167
[TBL] [Abstract][Full Text] [Related]
17. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task.
Hazlett EA; Buchsbaum MS; Jeu LA; Nenadic I; Fleischman MB; Shihabuddin L; Haznedar MM; Harvey PD
Schizophr Res; 2000 May; 43(1):33-46. PubMed ID: 10828413
[TBL] [Abstract][Full Text] [Related]
18. Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
Nybäck H; Nyman H; Blomqvist G; Sjögren I; Stone-Elander S
J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):672-8. PubMed ID: 1719135
[TBL] [Abstract][Full Text] [Related]
19. Increased temporal lobe glucose use in chronic schizophrenic patients.
DeLisi LE; Buchsbaum MS; Holcomb HH; Langston KC; King AC; Kessler R; Pickar D; Carpenter WT; Morihisa JM; Margolin R
Biol Psychiatry; 1989 Apr; 25(7):835-51. PubMed ID: 2785820
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
